Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A5

    
• • ·Information for Authors

    Page :A6

    
• • ·Information for Readers

    Page :A8

    

• Editorials

  • ·The pathophysiology of acute heart failure—It is a lot about fluid accumulation

    Page :1-5

    Marco Metra, Livio Dei Cas, Michael R. Bristow

    Plan Plan
  • ·Establishing the effectiveness of coronary intervention for acute myocardial infarction

    Page :6-8

    William S. Weintraub, Deborah Ehrenthal

    

• Curriculum in Cardiology

  • ·The pathophysiology of acute heart failure—Is it all about fluid accumulation?

    Page :9-18

    Gad Cotter, G. Michael Felker, Kirkwood F. Adams, Olga Milo-Cotter, Christopher M. O'Connor

    Résumé Résumé Plan Plan  

• Trial Design

  • ·Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)

    Page :19-25

    Warren J. Cantor, David Fitchett, Bjug Borgundvaag, Michael Heffernan, Eric A. Cohen, Laurie J. Morrison, Anatoly Langer, Shamir Mehta, Charles Lazzam, Brian Schwartz, Vladimir Dzavik, Shaun G. Goodman

    Résumé Résumé Plan Plan  
  • ·Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)

    Page :26.e1

    Résumé Résumé Plan Plan
  • ·Monitoring the ACTIVE-W trial: Some issues in monitoring a noninferiority trial

    Page :33-41

    John A. Cairns, Janet Wittes, D. George Wyse, Janet Pogue, Michael Gent, Jack Hirsh, John Marler, Edward L.C. Pritchett

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Comparing invasive and noninvasive management strategies for acute myocardial infarction using administrative databases

    Page :42-48

    Louise Pilote, Christine A. Beck, Mark J. Eisenberg, Karin Humphries, Lawrence Joseph, John R. Penrod, Jack V. Tu

    Résumé Résumé Plan Plan
  • ·Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Theraphy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial

    Page :49-55

    David A. Morrow, Yunmei Wang, Kevin Croce, Masashi Sakuma, Marc S. Sabatine, Huiyun Gao, Aruna D. Pradhan, Aileen M. Healy, Jacki Buros, Carolyn H. McCabe, Peter Libby, Christopher P. Cannon, Eugene Braunwald, Daniel I. Simon

    Résumé Résumé Plan Plan   
  • ·Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction

    Page :55.e1

    Svein Solheim, Ingebjørg Seljeflot, Ketil Lunde, Pål Aukrust, Arne Yndestad, Haakon Kiil Grøgaard, Svend Aakhus, Kolbjørn Forfang, Harald Arnesen

    Résumé Résumé Plan Plan  
  • ·Biomarker analysis by fluorokine multianalyte profiling distinguishes patients requiring intervention from patients with long-term quiescent coronary artery disease: A potential approach to identify atherosclerotic disease progression

    Page :56-61

    Paul A. Gurbel, Rolf P. Kreutz, Kevin P. Bliden, Joseph DiChiara, Udaya S. Tantry

    Résumé Résumé Plan Plan
  • ·Kidney dysfunction and fatal cardiovascular disease—an association independent of atherosclerotic events: Results from the Health, Aging, and Body Composition (Health ABC) study

    Page :62-68

    Rajat Deo, Christina L. Wassel Fyr, Linda F. Fried, Anne B. Newman, Tamara B. Harris, Sara Angleman, Christie Green, Stephen B. Kritchevsky, Glenn M. Chertow, Steven R. Cummings, Michael G. Shlipak, for the Health ABC study

    Résumé Résumé Plan Plan  
  • ·Recovery of normal ventricular function in patients with dilated cardiomyopathy: Predictors of an increasingly prevalent clinical event

    Page :69-74

    Philip F. Binkley, Amanda Lesinski, Jeanette Pohorence Ferguson, Patricia S. Hatton, Laura Yamokoski, Sheetal Hardikar, Glen E. Cooke, Carl V. Leier

    Résumé Résumé Plan Plan
  • ·Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure

    Page :75-81

    Satoshi Suzuki, Yasuchika Takeishi, Takeshi Niizeki, Yo Koyama, Tatsuro Kitahara, Toshiki Sasaki, Mina Sagara, Isao Kubota

    Résumé Résumé Plan Plan  
  • ·Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)

    Page :82-86

    Luc Djoussé, Tobias Kurth, J. Michael Gaziano

    Résumé Résumé Plan Plan
  • ·Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality

    Page :87-93

    Kevin L. Thomas, Sana M. Al-Khatib, Yuliya Lokhnygina, Scott D. Solomon, Lars Kober, John J.V. McMurray, Robert M. Califf, Eric J. Velazquez

    Résumé Résumé Plan Plan  
  • ·Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: The PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) Trial

    Page :93.e1

    Victor L. Serebruany, Alex I. Malinin, Alex Pokov, Gregory Barsness, Dan F. Hanley

    Résumé Résumé Plan Plan  
  • ·Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients

    Page :94-99

    Evan Adelstein, Samir Saba

    Résumé Résumé Plan Plan  
  • ·A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: The Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial

    Page :100.e1

    Michele Gulizia, Salvatore Mangiameli, Serafino Orazi, Giacomo Chiarandà, Guglielmo Piccione, Nicolò Di Giovanni, Andrea Colletti, Orazio Pensabene, Francesco Lisi, Ludovico Vasquez, Andrea Grammatico, Giuseppe Boriani, on behalf of PITAGORA Study Investigators

    Résumé Résumé Plan Plan  
  • ·Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: Intravascular ultrasound results from ENDEAVOR III

    Page :108-113

    Akiyoshi Miyazawa, Junya Ako, Yoichiro Hongo, Seung-Ho Hur, Ichizo Tsujino, Brian K. Courtney, Ali H.M. Hassan, David E. Kandzari, Yasuhiro Honda, Peter J. Fitzgerald, for the ENDEAVOR III Investigators

    Résumé Résumé Plan Plan  
  • ·A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE)

    Page :113.e1

    Ik-Kyung Jang, Neil J. Weissman, Michael H. Picard, Michael R. Zile, Veronica Pettigrew, Steven Shen, Jun Tatsuno, Mark G. Hibberd, Dan Tzivoni, Frans J. Th. Wackers, the EVOLVE Investigators

    Résumé Résumé Plan Plan  
  • ·Risk-adjusted sequential probability ratio test control chart methods for monitoring operator and institutional mortality rates in interventional cardiology

    Page :114-120

    Michael E. Matheny, Lucila Ohno-Machado, Frederic S. Resnic

    Résumé Résumé Plan Plan  
  • ·Guideline adjudicated fibrinolytic failure: Incidence, findings, and management in a contemporary clinical trial

    Page :121-127

    Christopher E. Buller, Robert C. Welsh, Cynthia M. Westerhout, John G. Webb, Blair O'Neill, Richard Gallo, Paul W. Armstrong

    Résumé Résumé Plan Plan  
  • ·Use of endothelial progenitor cell capture stent (Genous Bio-Engineered R Stent) during primary percutaneous coronary intervention in acute myocardial infarction: Intermediate- to long-term clinical follow-up

    Page :128-132

    Melissa Co, Edgar Tay, Chi Hang Lee, Kian Keong Poh, Adrian Low, Jimmy Lim, Ing Han Lim, Yean Teng Lim, Huay Cheem Tan

    Résumé Résumé Plan Plan
  • ·Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: A Clopidogrel as Adjunctive Reperfusion Therapy–Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study

    Page :133-139

    C. Michael Gibson, Sabina A. Murphy, Yuri B. Pride, Ajay J. Kirtane, Julian M. Aroesty, Erica B. Stein, Lauren N. Ciaglo, Matthew C. Southard, Marc S. Sabatine, Christopher P. Cannon, Eugene Braunwald, for the TIMI Study Group

    Résumé Résumé Plan Plan  
  • ·Culprit-only or multivessel revascularization in patients with acute coronary syndromes : An American College of Cardiology National Cardiovascular Database Registry report

    Page :140-146

    Sorin J. Brener, Sarah Milford-Beland, Matthew T. Roe, Deepak L. Bhatt, William S. Weintraub, Ralph G. Brindis

    Résumé Résumé Plan Plan  
  • ·Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: Insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study

    Page :147-153

    Harikrishna Tandri, Robson Macedo, Hugh Calkins, Frank Marcus, David Cannom, Melvin Scheinman, James Daubert, Mark Estes, David Wilber, Mario Talajic, Henry Duff, Andrew Krahn, Michael Sweeney, Hasan Garan, David A. Bluemke, for the Multidisciplinary Study of Right Ventricular Dysplasia Investigators

    Résumé Résumé Plan Plan  
  • ·Predictive value of coronary calcifications for future cardiac events in asymptomatic individuals

    Page :154-160

    Alexander Becker, Alexander Leber, Christoph Becker, Andreas Knez

    Résumé Résumé Plan Plan  
  • ·Failure of digital echocardiography to accurately diagnose intracardiac shunts

    Page :161-165

    Hind W. Rahmouni, Martin G. Keane, Frank E. Silvestry, Martin G. St. John Sutton, Victor A. Ferrari, Craig H. Scott, Susan E. Wiegers

    Résumé Résumé Plan Plan  
  • ·Pulmonary vascular input impedance is a combined measure of pulmonary vascular resistance and stiffness and predicts clinical outcomes better than pulmonary vascular resistance alone in pediatric patients with pulmonary hypertension

    Page :166-174

    Kendall S. Hunter, Po-Feng Lee, Craig J. Lanning, D. Dunbar Ivy, K. Scott Kirby, Lori R. Claussen, K. Chen Chan, Robin Shandas

    Résumé Résumé Plan Plan  
  • ·Interactions of wine drinking with omega-3 fatty acids in patients with coronary heart disease: A fish-like effect of moderate wine drinking

    Page :175-181

    Michel de Lorgeril, Patricia Salen, Jean-Louis Martin, François Boucher, Joël de Leiris

    Résumé Résumé Plan Plan
  • ·Effect of pulmonary artery angioplasty on exercise function after repair of tetralogy of Fallot

    Page :182-186

    Nicole J. Sutton, Lynn Peng, James E. Lock, Peter Lang, Gerald R. Marx, Tracy J. Curran, Julie-Ann O'Neill, Sarah T. Picard, Jonathan Rhodes

    Résumé Résumé Plan Plan  
  • ·Increased central aortic stiffness and left ventricular mass in normotensive young subjects after successful coarctation repair

    Page :187-193

    Phalla Ou, David S. Celermajer, Odile Jolivet, Fanny Buyens, Alain Herment, Daniel Sidi, Damien Bonnet, Elie Mousseaux

    Résumé Résumé Plan Plan  

• Letter to the Editor

  • ·Letter to the Editor

    Page :e1

    Alberto Morales Salinas, Greter Lopez Morales, Ramiro Ramos Ramirez